HomeRYTM • NASDAQ
add
Rhythm Pharmaceuticals Inc
Previous close
$52.08
Day range
$48.31 - $52.21
Year range
$16.72 - $53.92
Market cap
3.00B USD
Avg Volume
582.70K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | 25.97M | 126.41% |
Operating expense | 163.05M | 160.55% |
Net income | -141.37M | -170.94% |
Net profit margin | -544.43 | -19.67% |
Earnings per share | -2.35 | -155.43% |
EBITDA | -139.48M | -167.85% |
Effective tax rate | -0.21% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 201.20M | -31.70% |
Total assets | 258.65M | -25.18% |
Total liabilities | 197.07M | 56.51% |
Total equity | 61.58M | — |
Shares outstanding | 60.97M | — |
Price to book | 51.56 | — |
Return on assets | -118.27% | — |
Return on capital | -156.41% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -141.37M | -170.94% |
Cash from operations | -40.74M | -11.83% |
Cash from investing | 30.05M | 62.75% |
Cash from financing | 4.24M | 3,290.23% |
Net change in cash | -6.52M | 63.80% |
Free cash flow | -125.43M | -338.74% |
About
Founded
Nov 2008
Headquarters
Website
Employees
226